Abstract
Patients with relapsed Hodgkin's disease who respond to salvage therapy are successfully treated with cyclophosphamide, carmustine (BCNU), and etoposide (VP-16) (CBV) followed by autologous bone marrow transplantation (ABMT). Because of heavy pretreatment including radiation to the pelvic site, marrow harvest was not feasible in those patients. We therefore used blood-derived hemopoietic precursor cells as an alternative stem-cell source to rescue them after superdose chemotherapy. Hemopoietic precursor cells were mobilized into the peripheral blood either by chemotherapeutic induction of transient myelosuppression followed by an overshooting of blood stem-cell concentration, or by continuous intravenous (IV) granulocyte-macrophage colony-stimulating factor (GMCSF) administration. The median time to reach 1,000 WBC per microliter, 500 polymorphonuclear cells (PMN)
| Original language | English (US) |
|---|---|
| Pages (from-to) | 978-985 |
| Number of pages | 8 |
| Journal | Journal of Clinical Oncology |
| Volume | 8 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1990 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS